• Navigating FDA clinical trials in Neurotech with Tim Marjenin

  • Aug 23 2024
  • Duración: 41 m
  • Podcast

Navigating FDA clinical trials in Neurotech with Tim Marjenin

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Greg and Matias interview Tim Marjenin, a regulatory consultant at MCRA with 16 years of experience at the FDA, to discuss the regulatory landscape for neurotechnology devices.

    Tim provides insights into the FDA approval process for neurotech devices, drawing from his extensive experience on the FDA's Neurostimulation-Neurology Devices Team. The episode explores the evolving field of neurotechnology and its regulatory challenges.

    In this episode, we discuss:

    • Different regulatory pathways for neurological devices (510(k), De Novo, PMA)
    • FDA's approach to novel neurotechnologies like brain-computer interfaces (BCIs)
    • Considerations for invasive vs. non-invasive neurotech devices
    • The importance of cybersecurity in neurotechnology
    • Common mistakes companies make in the regulatory process and how to avoid them
    • The potential future of neurotechnology, including human augmentation and telepathy

    Created by Greg Kubin and Matias Serebrinsky
    Host: Matias Serebrinsky & Greg Kubin
    Produced by Jonathan A. Davis, Nico V. Rey & Caitlin Ner

    Find us at businesstrip.fm and psymed.ventures
    Follow us on Instagram and Twitter!
    Theme music by Dorian Love
    Additional Music: Distant Daze by Zack Frank and Krotoa by Makropulos
    Más Menos
Medicina Alternativa y Complementaria Psicología Hygiene & Healthy Living Ciencia
Más Menos

Lo que los oyentes dicen sobre Navigating FDA clinical trials in Neurotech with Tim Marjenin

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles